JAADi-Supplementary Materials-Okada Y et al. Real-world effectiveness and safety of every-four-week lebrikizumab maintenance dosing from Week 4 following two loading doses in Japanese patients with atopic dermatitis
收藏NIAID Data Ecosystem2026-05-10 收录
官方服务：
资源简介：
JAAD International Supplementary Materials Okada Y et al. Real-world effectiveness and safety of every-four-week lebrikizumab maintenance dosing from Week 4 following two loading doses in Japanese patients with atopic dermatitis
创建时间：
2025-11-20
